Summary
The selection of appropriate cancer models is a key prerequisite for maximising translational potential and clinical relevance of in-vitro oncology studies.
We developed CELLector: a computational method (implemented in an open source R Shiny application and R package) allowing researchers to select the most relevant cancer cell lines in a patient-genomic guided fashion. CELLector leverages tumour genomics data to identify recurrent sub-types with associated genomic signatures. It then evaluates these signatures in cancer cell lines to rank them and prioritise their selection. This enables users to choose appropriate models for inclusion/exclusion in retrospective analyses and future studies. Moreover this allows bridging data from cancer cell line screens to precisely defined sub-cohorts of primary tumours. Here, we demonstrate usefulness and applicability of our method through example use cases, showing how it can be used to prioritise the development of new in-vitro models and to effectively unveil patient-derived multivariate prognostic and therapeutic markers.
Graphical Abstract
Footnotes
↵8 Lead Contact